T-helper epitopes on human nicotinic acetylcholine receptor in Myasthenia gravis

L. Moiola, M. P. Protti, A. O. Manfredi, M. H. Yuen, J. F. Howard, B. M. Conti-Tronconi

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The synthesis of AChR antibodies requires intervention of AChR-specific Th cells. Because of the paucity of anti-AChR Th cells in the blood of myasthenia gravis (MG) patients, direct studies of these autoimmune cells in the blood are seldom possible. Propagation in vitro of anti-AChR T cells from MG patients by cycles of stimulation with AChR antigens selectively enriches and expands the autoimmune T-cell clones, allowing investigation of their function and epitope specificity. Torpedo electroplax AChR was initially used for propagation of antiAChR T-cell lines. Those studies demonstrated the feasibility of in vitro propagation of AChR-specific T cells. These are bona fide CD4+ Th cells, which stimulate production in vitro of anti-AChR antibodies by B cells of myasthenic patients and recognize equally well denatured and native AChR, suggesting the usefulness of synthetic human AChR sequences as antigens for propagation of the autoimmune Th cells. We used pools of overlapping synthetic peptides, corresponding to the complete sequences of the human AChR α-, β-, γ-, and δ-subunits, to propagate AChR-specific Th cells from the blood of MG patients. The AChR sequence regions forming epitopes recognized by the autoimmune T cells were determined by challenging the lines with individual synthetic peptides, 20 residues long, screening the AChR subunit sequences. Although each line had an individual pattern of epitope recognition as expected from their different HLA-DR haplotypesome peptides were recognized by most or all the CD4+ T-cell lines, irrespective of their DR haplotype. The existence of immunodominant regions of the AChR sequence was verified by investigating the response of unselected CD4+ cells from the blood of a relatively large number of MG patients to the individual peptides screening the human α-, γ-, and δ-subunit sequences. Those studies confirmed that each patient has an individual pattern of peptide recognition. The studies also identified a large number of T epitopes of the human AChR and verified the existence of sequence regions immunodominant for T-helper sensitization, because a limited number of sequence regions, including all those immunodominant for the T-helper lines, were recognized by most patients. Anti-AChR CD4+ T lines could be propagated from some healthy controls only for a brief period of time. They recognized AChR sequences poorly, suggesting a low affinity of their T-cell receptors for the corresponding AChR epitopes. Most MG patients have CD4+ cells specific for the embryonic form of muscle AChR, which in skeletal muscles disappears after innervation, suggesting that initiation of the anti-AChR immune response may occur in a tissue(s) other than innervated skeletal muscle, and possibly within the thymus, which expresses a protein similar or identical to embryonic muscle AChR. The response of CD4+ cells to AChR epitopes is inhibited by CD8+ cells, which recognize - in a class I MHC-restricted fashion - a structure (structures) present on antigen-activated CD4+ cells.

Original languageEnglish
Pages (from-to)198-218
Number of pages21
JournalAnnals of the New York Academy of Sciences
Volume681
Publication statusPublished - 1993

Fingerprint

T-cells
Myasthenia Gravis
Nicotinic Receptors
Epitopes
Muscle
Blood
Peptides
T-Lymphocytes
Immunodominant Epitopes
Blood Cells
Antigens
Screening
Thymus
Skeletal Muscle
Antibodies
HLA-DR Antigens
T-Cell Antigen Receptor
Torpedo
Cell Line
Muscles

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

T-helper epitopes on human nicotinic acetylcholine receptor in Myasthenia gravis. / Moiola, L.; Protti, M. P.; Manfredi, A. O.; Yuen, M. H.; Howard, J. F.; Conti-Tronconi, B. M.

In: Annals of the New York Academy of Sciences, Vol. 681, 1993, p. 198-218.

Research output: Contribution to journalArticle

@article{078d957398dd4652b6c825b38d089ef9,
title = "T-helper epitopes on human nicotinic acetylcholine receptor in Myasthenia gravis",
abstract = "The synthesis of AChR antibodies requires intervention of AChR-specific Th cells. Because of the paucity of anti-AChR Th cells in the blood of myasthenia gravis (MG) patients, direct studies of these autoimmune cells in the blood are seldom possible. Propagation in vitro of anti-AChR T cells from MG patients by cycles of stimulation with AChR antigens selectively enriches and expands the autoimmune T-cell clones, allowing investigation of their function and epitope specificity. Torpedo electroplax AChR was initially used for propagation of antiAChR T-cell lines. Those studies demonstrated the feasibility of in vitro propagation of AChR-specific T cells. These are bona fide CD4+ Th cells, which stimulate production in vitro of anti-AChR antibodies by B cells of myasthenic patients and recognize equally well denatured and native AChR, suggesting the usefulness of synthetic human AChR sequences as antigens for propagation of the autoimmune Th cells. We used pools of overlapping synthetic peptides, corresponding to the complete sequences of the human AChR α-, β-, γ-, and δ-subunits, to propagate AChR-specific Th cells from the blood of MG patients. The AChR sequence regions forming epitopes recognized by the autoimmune T cells were determined by challenging the lines with individual synthetic peptides, 20 residues long, screening the AChR subunit sequences. Although each line had an individual pattern of epitope recognition as expected from their different HLA-DR haplotypesome peptides were recognized by most or all the CD4+ T-cell lines, irrespective of their DR haplotype. The existence of immunodominant regions of the AChR sequence was verified by investigating the response of unselected CD4+ cells from the blood of a relatively large number of MG patients to the individual peptides screening the human α-, γ-, and δ-subunit sequences. Those studies confirmed that each patient has an individual pattern of peptide recognition. The studies also identified a large number of T epitopes of the human AChR and verified the existence of sequence regions immunodominant for T-helper sensitization, because a limited number of sequence regions, including all those immunodominant for the T-helper lines, were recognized by most patients. Anti-AChR CD4+ T lines could be propagated from some healthy controls only for a brief period of time. They recognized AChR sequences poorly, suggesting a low affinity of their T-cell receptors for the corresponding AChR epitopes. Most MG patients have CD4+ cells specific for the embryonic form of muscle AChR, which in skeletal muscles disappears after innervation, suggesting that initiation of the anti-AChR immune response may occur in a tissue(s) other than innervated skeletal muscle, and possibly within the thymus, which expresses a protein similar or identical to embryonic muscle AChR. The response of CD4+ cells to AChR epitopes is inhibited by CD8+ cells, which recognize - in a class I MHC-restricted fashion - a structure (structures) present on antigen-activated CD4+ cells.",
author = "L. Moiola and Protti, {M. P.} and Manfredi, {A. O.} and Yuen, {M. H.} and Howard, {J. F.} and Conti-Tronconi, {B. M.}",
year = "1993",
language = "English",
volume = "681",
pages = "198--218",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - T-helper epitopes on human nicotinic acetylcholine receptor in Myasthenia gravis

AU - Moiola, L.

AU - Protti, M. P.

AU - Manfredi, A. O.

AU - Yuen, M. H.

AU - Howard, J. F.

AU - Conti-Tronconi, B. M.

PY - 1993

Y1 - 1993

N2 - The synthesis of AChR antibodies requires intervention of AChR-specific Th cells. Because of the paucity of anti-AChR Th cells in the blood of myasthenia gravis (MG) patients, direct studies of these autoimmune cells in the blood are seldom possible. Propagation in vitro of anti-AChR T cells from MG patients by cycles of stimulation with AChR antigens selectively enriches and expands the autoimmune T-cell clones, allowing investigation of their function and epitope specificity. Torpedo electroplax AChR was initially used for propagation of antiAChR T-cell lines. Those studies demonstrated the feasibility of in vitro propagation of AChR-specific T cells. These are bona fide CD4+ Th cells, which stimulate production in vitro of anti-AChR antibodies by B cells of myasthenic patients and recognize equally well denatured and native AChR, suggesting the usefulness of synthetic human AChR sequences as antigens for propagation of the autoimmune Th cells. We used pools of overlapping synthetic peptides, corresponding to the complete sequences of the human AChR α-, β-, γ-, and δ-subunits, to propagate AChR-specific Th cells from the blood of MG patients. The AChR sequence regions forming epitopes recognized by the autoimmune T cells were determined by challenging the lines with individual synthetic peptides, 20 residues long, screening the AChR subunit sequences. Although each line had an individual pattern of epitope recognition as expected from their different HLA-DR haplotypesome peptides were recognized by most or all the CD4+ T-cell lines, irrespective of their DR haplotype. The existence of immunodominant regions of the AChR sequence was verified by investigating the response of unselected CD4+ cells from the blood of a relatively large number of MG patients to the individual peptides screening the human α-, γ-, and δ-subunit sequences. Those studies confirmed that each patient has an individual pattern of peptide recognition. The studies also identified a large number of T epitopes of the human AChR and verified the existence of sequence regions immunodominant for T-helper sensitization, because a limited number of sequence regions, including all those immunodominant for the T-helper lines, were recognized by most patients. Anti-AChR CD4+ T lines could be propagated from some healthy controls only for a brief period of time. They recognized AChR sequences poorly, suggesting a low affinity of their T-cell receptors for the corresponding AChR epitopes. Most MG patients have CD4+ cells specific for the embryonic form of muscle AChR, which in skeletal muscles disappears after innervation, suggesting that initiation of the anti-AChR immune response may occur in a tissue(s) other than innervated skeletal muscle, and possibly within the thymus, which expresses a protein similar or identical to embryonic muscle AChR. The response of CD4+ cells to AChR epitopes is inhibited by CD8+ cells, which recognize - in a class I MHC-restricted fashion - a structure (structures) present on antigen-activated CD4+ cells.

AB - The synthesis of AChR antibodies requires intervention of AChR-specific Th cells. Because of the paucity of anti-AChR Th cells in the blood of myasthenia gravis (MG) patients, direct studies of these autoimmune cells in the blood are seldom possible. Propagation in vitro of anti-AChR T cells from MG patients by cycles of stimulation with AChR antigens selectively enriches and expands the autoimmune T-cell clones, allowing investigation of their function and epitope specificity. Torpedo electroplax AChR was initially used for propagation of antiAChR T-cell lines. Those studies demonstrated the feasibility of in vitro propagation of AChR-specific T cells. These are bona fide CD4+ Th cells, which stimulate production in vitro of anti-AChR antibodies by B cells of myasthenic patients and recognize equally well denatured and native AChR, suggesting the usefulness of synthetic human AChR sequences as antigens for propagation of the autoimmune Th cells. We used pools of overlapping synthetic peptides, corresponding to the complete sequences of the human AChR α-, β-, γ-, and δ-subunits, to propagate AChR-specific Th cells from the blood of MG patients. The AChR sequence regions forming epitopes recognized by the autoimmune T cells were determined by challenging the lines with individual synthetic peptides, 20 residues long, screening the AChR subunit sequences. Although each line had an individual pattern of epitope recognition as expected from their different HLA-DR haplotypesome peptides were recognized by most or all the CD4+ T-cell lines, irrespective of their DR haplotype. The existence of immunodominant regions of the AChR sequence was verified by investigating the response of unselected CD4+ cells from the blood of a relatively large number of MG patients to the individual peptides screening the human α-, γ-, and δ-subunit sequences. Those studies confirmed that each patient has an individual pattern of peptide recognition. The studies also identified a large number of T epitopes of the human AChR and verified the existence of sequence regions immunodominant for T-helper sensitization, because a limited number of sequence regions, including all those immunodominant for the T-helper lines, were recognized by most patients. Anti-AChR CD4+ T lines could be propagated from some healthy controls only for a brief period of time. They recognized AChR sequences poorly, suggesting a low affinity of their T-cell receptors for the corresponding AChR epitopes. Most MG patients have CD4+ cells specific for the embryonic form of muscle AChR, which in skeletal muscles disappears after innervation, suggesting that initiation of the anti-AChR immune response may occur in a tissue(s) other than innervated skeletal muscle, and possibly within the thymus, which expresses a protein similar or identical to embryonic muscle AChR. The response of CD4+ cells to AChR epitopes is inhibited by CD8+ cells, which recognize - in a class I MHC-restricted fashion - a structure (structures) present on antigen-activated CD4+ cells.

UR - http://www.scopus.com/inward/record.url?scp=0027312696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027312696&partnerID=8YFLogxK

M3 - Article

C2 - 7689306

AN - SCOPUS:0027312696

VL - 681

SP - 198

EP - 218

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -